Dow Up 0.11% Nasdaq Up 0.50%

ACADIA Pharmaceuticals Inc. (ACAD)

-NasdaqGS
23.98 Up 0.37(1.57%) Aug 29, 4:00PM EDT
|After Hours : 23.98 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Prev Close:23.61
Open:23.61
Bid:23.47 x 5000
Ask:23.95 x 100
1y Target Est:33.60
Beta:2.75
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:23.58 - 24.14
52wk Range:15.64 - 32.00
Volume:636,507
Avg Vol (3m):989,342
Market Cap:2.38B
P/E (ttm):N/A
EPS (ttm):-0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACAD

Comparison

Symbol% ChgMkt Cap
ACADUp 1.57%2.38B
AZNUp 2.38%96.00B
LLYUp 0.71%68.12B
PFEUp 0.03%186.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7,008.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.86
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.39

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback